PIEB vs CEI for Labor Analgesia: An MLAC Study

NCT02573597 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2022-10-18

Study results available
· View outcomes & findings →

Summary

Utilizing a 'minimal local analgesic concentration (MLAC) study' design to first determine the relative potency of Programmed Intermittent Epidural Bolus (PIEB) compared to Continuous Epidural Infusion (CEI) and secondly to determine the mechanism to explain the potential PIEB efficacy advantage.

Conditions

  • Pregnancy

Interventions

DRUG

Bupivacaine

Continuous or bolus administration

DRUG

Sufentanil

Continuous or bolus administration

Sponsors & Collaborators

  • Manchester University NHS Foundation Trust

    collaborator OTHER_GOV
  • Stanford University

    lead OTHER

Principal Investigators

  • Brendan Carvalho, MBBCh, MDCH · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-05-22
Completion
2018-05-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02573597 on ClinicalTrials.gov